Pilot Investigation of Blood Pressure Control Using a Mobile App (Cardi.Health): Retrospective Chart Review Study.

Q2 Medicine JMIR Cardio Pub Date : 2023-10-17 DOI:10.2196/48454
Marius Nakrys, Sarunas Valinskas, Kasparas Aleknavicius, Justinas Jonusas
{"title":"Pilot Investigation of Blood Pressure Control Using a Mobile App (Cardi.Health): Retrospective Chart Review Study.","authors":"Marius Nakrys,&nbsp;Sarunas Valinskas,&nbsp;Kasparas Aleknavicius,&nbsp;Justinas Jonusas","doi":"10.2196/48454","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The high prevalence of hypertension necessitates effective, scalable interventions for blood pressure (BP) control. Self-monitoring has shown improved adherence to medication and better BP management. Mobile apps offer a promising approach with their increasing popularity and potential for large-scale implementation. Studies have demonstrated associations between mobile app interventions and lowered BP, yet real-world data on app effectiveness and engagement remain limited.</p><p><strong>Objective: </strong>In this study, we analyzed real-world user data from the Cardi.Health mobile app, which is aimed at helping its users monitor and control their BP. Our goal was to find out whether there is an association between the use of the mobile app and a decrease in BP. Additionally, the study explored how engagement with the app may influence this outcome.</p><p><strong>Methods: </strong>This was a retrospective chart review study. The initial study population comprised 4407 Cardi.Health users who began using the app between January 2022 and April 2022. After applying inclusion criteria, the final study cohort comprised 339 users with elevated BP at the baseline. The sample consisted of 108 (31.9%) men and 231 (68.1%) women (P=.04). This retrospective chart review study obtained permission from the Biomedical Research Alliance of New York Institutional Review Board (June 2022, registration ID 22-08-503-939).</p><p><strong>Results: </strong>The study's main findings were that there is a possible relationship between use of the Cardi.Health mobile app and a decrease in systolic BP. Additionally, there was a significant association between active use of the app and systolic BP decrease (χ<sup>2</sup><sub>1</sub>=5.311; P=.02). Finally, active users had an almost 2 times greater chance of reducing systolic BP by 5 mm Hg or more over 4 weeks (odds ratio 1.932, 95% CI 1.074-3.528; P=.03).</p><p><strong>Conclusions: </strong>This study shows a possible relationship between Cardi.Health mobile app use and decreased BP. Additionally, engagement with the app may be related to better results-active use was associated with an almost 2-fold increase in the odds of reducing BP by 5 or more mm Hg.</p>","PeriodicalId":14706,"journal":{"name":"JMIR Cardio","volume":"7 ","pages":"e48454"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618889/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JMIR Cardio","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2196/48454","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The high prevalence of hypertension necessitates effective, scalable interventions for blood pressure (BP) control. Self-monitoring has shown improved adherence to medication and better BP management. Mobile apps offer a promising approach with their increasing popularity and potential for large-scale implementation. Studies have demonstrated associations between mobile app interventions and lowered BP, yet real-world data on app effectiveness and engagement remain limited.

Objective: In this study, we analyzed real-world user data from the Cardi.Health mobile app, which is aimed at helping its users monitor and control their BP. Our goal was to find out whether there is an association between the use of the mobile app and a decrease in BP. Additionally, the study explored how engagement with the app may influence this outcome.

Methods: This was a retrospective chart review study. The initial study population comprised 4407 Cardi.Health users who began using the app between January 2022 and April 2022. After applying inclusion criteria, the final study cohort comprised 339 users with elevated BP at the baseline. The sample consisted of 108 (31.9%) men and 231 (68.1%) women (P=.04). This retrospective chart review study obtained permission from the Biomedical Research Alliance of New York Institutional Review Board (June 2022, registration ID 22-08-503-939).

Results: The study's main findings were that there is a possible relationship between use of the Cardi.Health mobile app and a decrease in systolic BP. Additionally, there was a significant association between active use of the app and systolic BP decrease (χ21=5.311; P=.02). Finally, active users had an almost 2 times greater chance of reducing systolic BP by 5 mm Hg or more over 4 weeks (odds ratio 1.932, 95% CI 1.074-3.528; P=.03).

Conclusions: This study shows a possible relationship between Cardi.Health mobile app use and decreased BP. Additionally, engagement with the app may be related to better results-active use was associated with an almost 2-fold increase in the odds of reducing BP by 5 or more mm Hg.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
使用移动应用程序控制血压的初步调查(Cardi.Health):回顾性图表回顾研究。
背景:高血压的高患病率需要有效、可扩展的血压控制干预措施。自我监测显示,药物依从性得到改善,血压管理也得到改善。移动应用程序提供了一种很有前景的方法,因为它们越来越受欢迎,并有可能大规模实施。研究表明,移动应用干预与血压降低之间存在关联,但关于应用有效性和参与度的真实数据仍然有限。目的:在本研究中,我们分析了来自Cardi的真实世界用户数据。健康移动应用程序,旨在帮助用户监测和控制血压。我们的目标是找出移动应用程序的使用与血压下降之间是否存在关联。此外,该研究还探讨了与应用程序的互动如何影响这一结果。方法:这是一项回顾性图表回顾性研究。最初的研究人群包括4407名卡迪人。在2022年1月至2022年4月期间开始使用该应用程序的健康用户。应用纳入标准后,最终研究队列包括339名基线血压升高的用户。样本包括108名(31.9%)男性和231名(68.1%)女性(P=0.04)。这项回顾性图表审查研究获得了纽约机构审查委员会生物医学研究联盟的许可(2022年6月,注册号22-08-503-939)。结果:该研究的主要发现是,Cardi的使用之间可能存在关系。健康手机应用程序和收缩压下降。此外,积极使用该应用程序与收缩压下降之间存在显著关联(χ21=5.311;P=0.02)。最后,活跃用户在4周内将收缩压降低5毫米汞柱或更多的几率几乎高出2倍(比值比1.932,95%CI 1.074-3.528;P=0.03)。结论:本研究表明Cardi之间可能存在关系。健康手机应用程序的使用和血压的下降。此外,使用该应用程序可能与更好的结果有关。积极使用该应用可使血压降低5毫米汞柱或更多毫米汞柱的几率增加近2倍。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
JMIR Cardio
JMIR Cardio Computer Science-Computer Science Applications
CiteScore
3.50
自引率
0.00%
发文量
25
审稿时长
12 weeks
期刊最新文献
Predicting Atrial Fibrillation Relapse Using Bayesian Networks: Explainable AI Approach. Wearable Electrocardiogram Technology: Help or Hindrance to the Modern Doctor? Technology Readiness Level and Self-Reported Health in Recipients of an Implantable Cardioverter Defibrillator: Cross-Sectional Study. A Medication Management App (Smart-Meds) for Patients After an Acute Coronary Syndrome: Pilot Pre-Post Mixed Methods Study. Causal Inference for Hypertension Prediction With Wearable E lectrocardiogram and P hotoplethysmogram Signals: Feasibility Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1